✦ LIBER ✦

A cost-utility analysis of clopidogrel in patients with ST elevation acute coronary syndromes in the UK

✍ Scribed by Jonathan Karnon; Mike W. Holmes; Robert Williams; Ameet Bakhai; Alan Brennan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A cost-utility analysis of clopidogrel i

✍ J. Karnon; A. Bakhai; A. Brennan; A. Pandor; M. Flather; E. Warren; D. Gray; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Using Clopidogrel in Non-ST-Segment Elev

✍ Jaime Latour-Pérez; Andrés Navarro-Ruiz; Manuel Ridao-López; Manuel Cervera-Mont 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

PCV1 COST-EFFECTIVENESS ANALYSIS OF CLOP

✍ K Borsos; B Nagy; J Spiesser; S Gabriel; G Blaskó 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Benefit of clopidogrel in patients with

✍ A. Budaj; S. Yusuf; S.R. Mehta 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Long-term cost-effectiveness of clopidog

✍ B. Brüggenjürgen; P. Lindgren; B. Ehlken; H.-J. Rupprecht; S. N. Willich 📂 Article 📅 2006 🏛 Springer 🌐 French ⚖ 178 KB

Hospital stay in patients with non-ST-el

✍ Nick G Bellenger; Jonas Eichhöfer; Dorothy Crone; Nicholas Curzen 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 58 KB